Career history of Alfred Kingsley
Former positions of Alfred Kingsley
Companies | Position | Start | End |
---|---|---|---|
Greenway Partners LP
Greenway Partners LP Investment ManagersFinance Greenway Partners LP is the hedge fund management subsidiary of Greenbelt Corp. Headquartered in New York City, the firm manages the assets of high-net-worth clients. | Chief Investment Officer | 1993-04-30 | 2024-04-23 |
Portfolio Manager-Equities | 1993-04-30 | 2024-04-23 | |
President | 1993-04-30 | 2024-04-23 | |
LINEAGE CELL THERAPEUTICS, INC. | Chairman | 2009-07-07 | 2024-04-23 |
Greenbelt Corp.
Greenbelt Corp. Investment ManagersFinance Greenbelt Corp. operates as a business consulting firm. The company is headquartered in New York, NY. | President | 1992-12-31 | 2024-04-23 |
ES Cell International Pte Ltd.
ES Cell International Pte Ltd. BiotechnologyHealth Technology ES Cell International Pte Ltd. develops human embroyonic stem cell technologies for research and commercial applications. It develops an array of intellectual property in the fields of drug discovery, diagnostics, and therapeutics based on stem cell technology. The company was founded by Ariff Bongso, Robert Klupacs, Martin F. Pera, Reubinoff Benjamin and Alan Osborne Trounson in 2000 and is headquartered in Singapore. | Chairman | 2011-07-26 | 2024-04-23 |
ReCyte Therapeutics, Inc.
ReCyte Therapeutics, Inc. BiotechnologyHealth Technology ReCyte Therapeutics, Inc. operates as a regenerative medicine company. It focuses on repair of vascular disorders, including both age-related diseases and injuries. The company was founded in January 2011 and is headquartered in Alameda, CA. | Director/Board Member | 2010-12-31 | 2024-04-23 |
OrthoCyte Corp.
OrthoCyte Corp. Pharmaceuticals: MajorHealth Technology Part of Lineage Cell Therapeutics, Inc., OrthoCyte Corp. develops cellular therapeutics for orthopedic repair diseases and injuries. The company is based in Alameda, CA. The CEO of the company is Michael D. West. | Chairman | 2010-12-31 | 2024-04-23 |
BioTime Asia Ltd. | Chairman | 2010-12-31 | 2024-04-23 |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | Director/Board Member | 2010-12-31 | 2024-04-23 |
Chairman | 2010-12-31 | - | |
ONCOCYTE CORPORATION | Director/Board Member | 2018-04-01 | 2024-04-23 |
Chairman | 2010-11-30 | 2018-04-01 | |
Independent Dir/Board Member | - | 2024-04-23 | |
░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░ ░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Training of Alfred Kingsley
The Wharton School of the University of Pennsylvania | Undergraduate Degree |
New York University School of Law | Graduate Degree |
Statistics
International
United States | 14 |
Israel | 2 |
Singapore | 2 |
Operational
Chairman | 8 |
Director/Board Member | 6 |
President | 2 |
Sectoral
Health Technology | 10 |
Finance | 4 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
LINEAGE CELL THERAPEUTICS, INC. | Health Technology |
ONCOCYTE CORPORATION | Health Technology |
Private companies | 12 |
---|---|
Greenway Partners LP
Greenway Partners LP Investment ManagersFinance Greenway Partners LP is the hedge fund management subsidiary of Greenbelt Corp. Headquartered in New York City, the firm manages the assets of high-net-worth clients. | Finance |
Greenbelt Corp.
Greenbelt Corp. Investment ManagersFinance Greenbelt Corp. operates as a business consulting firm. The company is headquartered in New York, NY. | Finance |
ReCyte Therapeutics, Inc.
ReCyte Therapeutics, Inc. BiotechnologyHealth Technology ReCyte Therapeutics, Inc. operates as a regenerative medicine company. It focuses on repair of vascular disorders, including both age-related diseases and injuries. The company was founded in January 2011 and is headquartered in Alameda, CA. | Health Technology |
Asterias Biotherapeutics, Inc.
Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA. | Health Technology |
Icahn & Co., Inc.
Icahn & Co., Inc. Investment Banks/BrokersFinance Icahn & Co., Inc. provides security brokerage and dealership services. It focuses on risk arbitrage and options trading. It offers services to real estate development, oil and gas, railcar leasing, manufacturing, and technology firms. The company was founded in 1968 by Carl Icahn and is headquartered in New York, NY. | Finance |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | Health Technology |
ES Cell International Pte Ltd.
ES Cell International Pte Ltd. BiotechnologyHealth Technology ES Cell International Pte Ltd. develops human embroyonic stem cell technologies for research and commercial applications. It develops an array of intellectual property in the fields of drug discovery, diagnostics, and therapeutics based on stem cell technology. The company was founded by Ariff Bongso, Robert Klupacs, Martin F. Pera, Reubinoff Benjamin and Alan Osborne Trounson in 2000 and is headquartered in Singapore. | Health Technology |
OrthoCyte Corp.
OrthoCyte Corp. Pharmaceuticals: MajorHealth Technology Part of Lineage Cell Therapeutics, Inc., OrthoCyte Corp. develops cellular therapeutics for orthopedic repair diseases and injuries. The company is based in Alameda, CA. The CEO of the company is Michael D. West. | Health Technology |
BioTime Asia Ltd. | |
LifeMap Sciences, Inc.
LifeMap Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Atlas Capital Partners Ltd., LifeMap Sciences, Inc. is a company that provides stem cell information services. The company is based in Alameda, CA. The CEO of the company is Yaron Guan-Golan. LifeMap Sciences was acquired by Atlas Capital Partners Ltd. from AgeX Therapeutics, Inc. on March 15, 2021 for $0.50 million. | Commercial Services |
Ascendance Biotechnology, Inc.
Ascendance Biotechnology, Inc. BiotechnologyHealth Technology Ascendance Biotechnology, Inc. engages in the sale of cell-based assay products. It offers Hepregen and ESI Bio. The firm also offers stem cell technology. The company was founded by Vincent R. Zurawski, Jr. and Jeffrey D. Janus is headquartered in Alameda, CA. | Health Technology |
AgeX Therapeutics, Inc.
AgeX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AgeX Therapeutics, Inc. operates as a biotechnology company, which engages in the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its product pipeline includes AGEX-VASC1, AGEX-BAT1, and AGEX-iTR1547. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA. | Health Technology |
- Stock Market
- Insiders
- Alfred Kingsley
- Experience